GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▲ |
---|---|---|---|
2EIM | P00430 | Zinc ion binding structure of bovine heart cytochrome C oxidase in the fully reduced state | |
2EIM | P10175 | Zinc ion binding structure of bovine heart cytochrome C oxidase in the fully reduced state | |
2EIN | P00396 | Zinc ion binding structure of bovine heart cytochrome C oxidase in the fully oxidized state | |
2EIN | P68530 | Zinc ion binding structure of bovine heart cytochrome C oxidase in the fully oxidized state | |
2EIN | P00415 | Zinc ion binding structure of bovine heart cytochrome C oxidase in the fully oxidized state | |
2EIN | P00423 | Zinc ion binding structure of bovine heart cytochrome C oxidase in the fully oxidized state | |
2EIN | P00426 | Zinc ion binding structure of bovine heart cytochrome C oxidase in the fully oxidized state | |
2EIN | P00428 | Zinc ion binding structure of bovine heart cytochrome C oxidase in the fully oxidized state | |
2EIN | P07471 | Zinc ion binding structure of bovine heart cytochrome C oxidase in the fully oxidized state | |
2EIN | P00429 | Zinc ion binding structure of bovine heart cytochrome C oxidase in the fully oxidized state | |
2EIN | P04038 | Zinc ion binding structure of bovine heart cytochrome C oxidase in the fully oxidized state | |
2EIN | P07470 | Zinc ion binding structure of bovine heart cytochrome C oxidase in the fully oxidized state | |
2EIN | P13183 | Zinc ion binding structure of bovine heart cytochrome C oxidase in the fully oxidized state | |
2EIN | P00430 | Zinc ion binding structure of bovine heart cytochrome C oxidase in the fully oxidized state | |
2EIN | P10175 | Zinc ion binding structure of bovine heart cytochrome C oxidase in the fully oxidized state | |
2EJ1 | P71140 | Crystal structure of Cel44A, GH family 44 endoglucanase from Clostridium thermocellum | |
2EO7 | P71140 | Crystal structure of Cel44A, GH family 44 endoglucanase from Clostridium thermocellum | |
2EQD | P71140 | Crystal structure of Cel44A, GH family 44 endoglucanase from Clostridium thermocellum | |
2ERJ | P01589 | Crystal structure of the heterotrimeric interleukin-2 receptor in complex with interleukin-2 | |
2ERJ | P14784 | Crystal structure of the heterotrimeric interleukin-2 receptor in complex with interleukin-2 | |
2ERJ | P31785 | Crystal structure of the heterotrimeric interleukin-2 receptor in complex with interleukin-2 | |
2ERJ | P60568 | Crystal structure of the heterotrimeric interleukin-2 receptor in complex with interleukin-2 | |
2ERM | P05230 | Solution structure of a biologically active human FGF-1 monomer, complexed to a hexasaccharide heparin-analogue | |
2ERO | 11320556 | Crystal structure of vascular apoptosis-inducing protein-1(orthorhombic crystal form) | |
2ERP | 11320556 | Crystal structure of vascular apoptosis-inducing protein-1(inhibitor-bound form) | |
2ERQ | 11320556 | Crystal structure of vascular apoptosis-inducing protein-1(tetragonal crystal form) | |
2ESC | P30922 | Crystal structure of a 40 KDa protective signalling protein from Bovine (SPC-40) at 2.1 A resolution | |
2ESR | 50914635 | conserved hypothetical protein- streptococcus pyogenes | |
2ETE | P45850 | Recombinant oxalate oxidase in complex with glycolate | |
2EUK | Q9NZD2 | Crystal Structure of Human Glycolipid Transfer Protein complexed with 24:1 Galactosylceramide | |
2EUM | Q9NZD2 | Crystal structure of human Glycolipid Transfer Protein complexed with 8:0 Lactosylceramide | |
2EVD | Q9NZD2 | Crystal structure of human Glycolipid Transfer Protein complexed with 12:0 Lactosylceramide | |
2EVL | Q9NZD2 | Crystal structure of human Glycolipid Transfer Protein complexed with 18:2 Galactosylceramide | |
2EVS | Q9NZD2 | Crystal structure of human Glycolipid Transfer Protein complexed with n-hexyl-beta-D-glucoside | |
2EVU | Q9C4Z5 | Crystal structure of aquaporin AqpM at 2.3A resolution | |
2EWE | P11073 | Crystal structure of Pectate Lyase C R218K mutant in complex with pentagalacturonic acid | |
2EXJ | Q68HB3 | Structure of the family43 beta-Xylosidase D128G mutant from geobacillus stearothermophilus in complex with xylobiose | |
2EXK | Q68HB3 | Structure of the family43 beta-Xylosidase E187G from geobacillus stearothermophilus in complex with xylobiose | |
2F0Z | Q9Y3R4 | Crystal Structure of the Human Sialidase Neu2 in Complex with Zanamivir inhibitor | |
2F11 | Q9Y3R4 | Crystal Structure of the Human Sialidase Neu2 in Complex with isobutyl ether mimetic Inhibitor | |
2F12 | Q9Y3R4 | Crystal Structure of the Human Sialidase Neu2 in Complex with 3- hydroxypropyl ether mimetic Inhibitor | |
2F13 | Q9Y3R4 | Crystal Structure of the Human Sialidase Neu2 in Complex with 2',3'- dihydroxypropyl ether mimetic Inhibitor | |
2F18 | 517481 | GOLGI ALPHA-MANNOSIDASE II complex with (2R,3R,4S)-2-({[(1R)-2-hydroxy-1-phenylethyl]amino}methyl)pyrrolidine-3,4-diol | |
2F1A | 517481 | GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH (2R,3R,4S)-2-({[(1S)-2-hydroxy-1-phenylethyl]amino}methyl)pyrrolidine-3,4-diol | |
2F1B | 517481 | GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH (2R,3R,4S,5R)-2-({[(1R)-2-hydroxy-1-phenylethyl]amino}methyl)-5-methylpyrrolidine-3,4-diol | |
2F25 | Q9Y3R4 | Crystal Structure of the Human Sialidase Neu2 E111Q Mutant in Complex with DANA Inhibitor | |
2F27 | Q9Y3R4 | Crystal Structure of the Human Sialidase Neu2 E111Q-Q112E Double Mutant in Complex with DANA Inhibitor | |
2F29 | Q9Y3R4 | Crystal Structure of the Human Sialidase Neu2 Q116E Mutant in Complex with DANA Inhibitor | |
2F2E | Q9I3B4 | Crystal Structure of PA1607, a Putative Transcription Factor | |
2F2L | Q9GNK5 | Crystal structure of tracheal cytotoxin (TCT) bound to the ectodomain complex of peptidoglycan recognition proteins LCa (PGRP-LCa) and LCx (PGRP-LCx) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024